Clinical Trials on Pseudohypoparathyroidism Type 1a in Poland

Total 4214 results

Erasmus Medical Center

Recruiting

Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors (PRRT-PARPi)

Neuroendocrine Tumors | Peptide Receptor Radionuclide Therapy

Netherlands
Providence Health & Services

Terminated

Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)

Melanoma

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Leiden University Medical Center; ISA Pharmaceuticals B.V.

Completed

Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia (VACCAIN-T)

HIV | Anal Intraepithelial Neoplasia

Netherlands
Paola Anna Erba
Erasmus Medical Center; Jagiellonian University; Medical University Innsbruck; University... and other collaborators

Completed

Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC (GRAN-T-MTC)

Medullary Thyroid Carcinoma

Austria, Germany, Netherlands, Poland, Slovenia
Academisch Medisch Centrum - Universiteit van Amsterdam...
Endogenex

Recruiting

A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2) (EMINENT-2)

Diabetes Mellitus, Type 2

Netherlands
The Netherlands Cancer Institute

Recruiting

Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery (MATISSE)

Cutaneous Squamous Cell Carcinoma

Netherlands
National Center for Complementary and Integrative...

Completed

Pilot Study of Vedic Medicine for Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Eli Lilly and Company

Completed

Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) (S019)

Diabetes Mellitus, Type 2

Croatia, Poland, Romania, South Africa, Turkey
European Mantle Cell Lymphoma Network
Nordic Lymphoma Group; HOVON - Dutch Haemato-Oncology Association; Lymphoma Study... and other collaborators

Unknown

Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL (MCLelderly)

Lymphoma, Mantle-Cell

Czech Republic, Denmark, France, Germany, Italy, Netherlands, Poland
Leiden University Medical Center
Health Holland; Dutch Diabetes Research Foundation; IFOM, The FIRC Institute... and other collaborators

Completed

Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 Diabetes

Diabetes Mellitus, Type 2

Netherlands
AstraZeneca
Juvenile Diabetes Research Foundation

Completed

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Metformin And Chloroquine in IDH1/2-mutated Solid Tumors (MACIST)

Glioma | Cholangiocarcinoma | Chondrosarcoma

Netherlands
Celon Pharma SA
National Center for Research and Development, Poland

Recruiting

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

Sarcoma | Gastric Cancer | Cholangiocarcinoma | Bladder Cancer | Endometrial Cancer | Squamous Non-small Cell Lung Cancer | Other Solid Tumours

Poland
Academisch Medisch Centrum - Universiteit van Amsterdam...
European Society of Anaesthesiology

Completed

QUANtification of Cardiovascular Autonomic Neuropathy (CAN) and the Effects of Anaesthesia on Haemodynamics and Cerebral Perfusion (QUANCAN)

Diabetes Mellitus, Type 2 | Anesthesia

Netherlands
Erasmus Medical Center

Recruiting

Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma (MOSAIC)

Glioblastoma

Netherlands
Providence Health & Services

Recruiting

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Primary Central Nervous System Lymphoma

United States
Ingrid Jazet
Merck Sharp & Dohme LLC

Completed

Sitagliptin and Brown Adipose Tissue (Sita01)

Neoplasms, Adipose Tissue

Netherlands
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma (Protocol-A)

Lymphoma

United States
Medtronic Diabetes

Completed

A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Hanmi Pharmaceutical Company Limited
Sanofi

Completed

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise (AMPLITUDE-M)

Type 2 Diabetes Mellitus

United States, Germany, Poland, Ukraine, United Kingdom
Academisch Medisch Centrum - Universiteit van Amsterdam...
University of Bologna; Bergman Clinics

Completed

Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors (CELTiC)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Carcinoma | Colorectal Polyp

Netherlands, Italy
Hoffmann-La Roche

Completed

A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma

Metastatic Melanoma

Belgium, Poland
Brown University
Pfizer; The Miriam Hospital; Rhode Island Hospital

Active, not recruiting

Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Providence Health & Services
Merck Sharp & Dohme LLC; Eisai Inc.

Recruiting

Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

Melanoma, Uveal

United States
Providence Health & Services
Prometheus Laboratories

Active, not recruiting

Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. (SBRT/IL-2)

Metastatic Melanoma

United States
OHSU Knight Cancer Institute

Completed

Vascular Response to Brachytherapy Using Functional OCT

Uveal Melanoma

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...

Completed

Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
Silesian Centre for Heart Diseases
Medical Research Agency, Poland

Not yet recruiting

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Heart Failure | Breast Cancer | Breast Diseases | Cardiotoxicity | Molecular Mechanisms of Pharmacological Action | Angiotensin Receptor Antagonists | Neoplasm, Breast | Cardiac Toxicity | Angiotensin II Type 1 Receptor Blockers | Cancer, Therapy-Related | Antihypertensive Agents | Sacubitril/Valsartan | Cancer...

Poland
JOTEC GmbH

Completed

A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting (ASSIST)

Type B Aortic Dissection

Germany, Spain, Poland, Italy
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Robert W. Franz...

Completed

Immunochemoradiotherapy in Patients With Pancreatic Cancer

Locally Advanced Pancreatic Adenocarcinoma

United States
Providence Health & Services

Withdrawn

Study of Immune Responses in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland
Erasmus Medical Center

Enrolling by invitation

Validation of SMS Protocol for HCC Screening in High-risk Patients

Hepatocellular Carcinoma

Netherlands
Cheryl Rosenfeld, DO
Amylin Pharmaceuticals, LLC.

Unknown

Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Erasmus Medical Center

Recruiting

Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma (PhysMRRT)

Glioblastoma

Netherlands
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Terminated

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Lymphoma

United States
OHSU Knight Cancer Institute

Completed

Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis

Melanoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Active, not recruiting

Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma

Glioblastoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma (Protocol-B)

Lymphoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Radiation Oncology Institute

Terminated

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Hepatocellular Carcinoma

United States
University of Chicago
National Institute on Minority Health and Health Disparities (NIMHD); Advocate... and other collaborators

Recruiting

Virtual Diabetes Group Visits Across Health Systems (VIDA)

Stroke | Hypertension | Obesity | Peripheral Vascular Diseases | Hyperlipidemias | T2DM (Type 2 Diabetes Mellitus) | Heart Disease Chronic

United States
Advanced Accelerator Applications

Active, not recruiting

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

Pheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine Tumors

United States, Spain, France, Poland, United Kingdom
Eisai Inc.

Completed

E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma

Soft Tissue Sarcoma

France, Germany, Belgium, Denmark, Poland
The Miriam Hospital
Brown University; Tufts Medical Center

Completed

Gene x Behavior Interaction in the Look AHEAD Study

Obesity | Type 2 Diabetes

United States
NovoCure GmbH

Unknown

Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)

Hepatocellular Carcinoma

Italy, Czechia, France, Germany, Poland, Spain
Amsterdam UMC, location VUmc

Recruiting

Function and Composition of Regulatory B Cells in Participants With Glioblastoma (GBMdexaB)

Glioblastoma, Adult

Netherlands
Amsterdam UMC, location VUmc

Unknown

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Cancer | High-grade Glioma

Netherlands
Erasmus Medical Center
Stichting Coolsingel

Unknown

Intraoperative Ultrasound Guided Glioma Surgery; a Randomised, Controlled Trial. (US-GLIOMA)

Glioma

Netherlands
AstraZeneca
Merck Sharp & Dohme LLC

Active, not recruiting

Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Neurofibromatosis Type 1

United States, Spain, Poland, Russian Federation

Clinical Trials on Pseudohypoparathyroidism Type 1a in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations